Bank Of America Corp Aurinia Pharmaceuticals Inc. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Bank Of America Corp holds 63,975 shares of AUPH stock, worth $498,365. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,975
Previous 174,690
63.38%
Holding current value
$498,365
Previous $1.28 Million
55.16%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AUPH
# of Institutions
229Shares Held
56.9MCall Options Held
858KPut Options Held
1.57M-
Black Rock Inc. New York, NY9.27MShares$72.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA8.43MShares$65.7 Million5.69% of portfolio
-
Armistice Capital, LLC New York, NY6.4MShares$49.9 Million0.81% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$30.9 Million2.55% of portfolio
-
State Street Corp Boston, MA2.92MShares$22.7 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.11B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...